Compare Xylem, Inc. (XYL) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Xylem, Inc. vs Zoetis Inc — how do they compare? Xylem, Inc. trades at $117.66 (market cap $28.67B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: Xylem, Inc. and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| XYL | ZTS | |
|---|---|---|
Market Cap | $28.67B | $31.95B |
Sector | Industrials | Health |
52-Week High | $152.95 | $156.76 |
52-Week Low | $106.34 | $71.91 |
Enterprise Value | $29.92B | $39.24B |
Dividend Yield | 1.43% | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Xylem, Inc.
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $6.2 billion in revenue and $611 million in adjusted operating income in 2021.
Read more on XYL →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
